How Artificial Intelligence Is Transforming the Fight Against Cancer: Diagnosis, Treatment, and Drug Discovery

Artificial intelligence is rapidly becoming a central force in the global fight against cancer. This in-depth article explains how AI is transforming every stage of oncology—from screening and early detection to digital pathology, radiotherapy planning, robotic surgery, drug discovery, and clinical trials. It highlights cutting-edge applications such as deep learning for medical imaging, whole-slide pathology analysis, radiomics and multi-omics biomarker discovery, AI-guided precision therapy, and real-world evidence analytics. The post also explores AI-powered patient support tools, ethical and regulatory challenges, and the importance of diverse data and explainable models. Drawing on recent high-impact reviews and authoritative sources, it positions AI as a powerful, evolving partner that augments clinicians rather than replacing them. For educators, healthcare professionals, and informed readers, this article serves as a comprehensive, authoritative resource on how AI is being employed against all forms of cancer—and where the field is heading next.

How Artificial Intelligence Is Transforming the Fight Against Cancer

Artificial intelligence (AI) is rapidly reshaping every stage of the cancer journey—from prevention and early detection to precision treatment, survivorship, and research. Once limited to experimental projects, AI is now embedded in clinical workflows, imaging suites, pathology labs, radiotherapy planning, and drug discovery pipelines. Major cancer centers, regulators, and technology companies are investing heavily in AI-driven oncology, and the pace of innovation is accelerating.

In this comprehensive overview, we explore how AI is being employed against all forms of cancer, highlight breakthrough applications, and examine the latest discoveries and treatments aided by AI. We will also look at the challenges of bias, transparency, and regulation—and what it will take for AI to become a trusted, routine partner in cancer care worldwide.

Why AI is uniquely suited to fight cancer

Cancer is not a single disease but a complex family of conditions driven by genetic, molecular, environmental, and lifestyle factors. Clinicians must interpret massive amounts of data: imaging scans, pathology slides, genomic profiles, lab results, treatment histories, and real-world outcomes. AI—especially machine learning and deep learning—excels at finding patterns in large, high-dimensional datasets that are difficult or impossible for humans to see.

Modern AI systems can:

• Integrate multimodal data: Combine imaging, pathology, genomics, and clinical records to build a holistic view of each patient.
• Detect subtle patterns: Identify early signs of cancer or treatment response that may be invisible to the human eye.
• Predict outcomes: Estimate risk of recurrence, survival, or toxicity to guide personalized treatment decisions.
• Optimize workflows: Automate repetitive tasks, triage cases, and free clinicians to focus on complex decisions and patient care.

These capabilities make AI a natural fit for precision oncology, where the goal is to deliver the right treatment to the right patient at the right time. Recent reviews in leading journals have documented how AI is becoming a core pillar of precision cancer care and research.

AI in cancer screening and early detection

AI-enhanced medical imaging

Imaging is often the first step in detecting cancer. AI-powered tools are now being used to analyze mammograms, CT scans, MRIs, PET scans, and low-dose CT lung screenings with remarkable accuracy. Deep learning models can flag suspicious lesions, measure tumor size, and compare current scans with prior images to detect subtle changes over time.

For example, AI systems for breast cancer screening have demonstrated performance comparable to or better than human radiologists in detecting early-stage tumors, while reducing false positives and unnecessary callbacks. Similar approaches are being applied to lung, prostate, colorectal, and brain cancers. Comprehensive reviews have shown that AI can significantly enhance lesion detection and characterization across multiple imaging modalities.

To explore the broader landscape of AI in cancer imaging, see this overview from the National Cancer Institute on AI in cancer imaging .

Risk prediction and population screening

Beyond reading individual scans, AI is being used to predict who is most likely to develop cancer in the future. Machine learning models can analyze electronic health records, lifestyle data, family history, and genetic information to estimate personalized risk scores. These scores can help health systems prioritize high-risk individuals for screening and preventive interventions.

AI-based risk prediction is particularly promising for cancers that currently lack effective screening programs, such as pancreatic and ovarian cancer. By identifying high-risk groups earlier, clinicians may be able to detect these cancers at more treatable stages.

AI in digital pathology and biomarker discovery

Whole-slide image analysis

Pathology—the microscopic examination of tissue—is the gold standard for cancer diagnosis. Traditionally, pathologists review glass slides manually, a time-consuming process that can be subject to inter-observer variability. AI-driven digital pathology systems convert slides into high-resolution images and use deep learning to identify cancer cells, grade tumors, and quantify features such as mitotic rate, necrosis, and immune cell infiltration.

Recent studies have shown that AI can match or exceed human performance in tasks like prostate cancer grading and lymph node metastasis detection, while dramatically speeding up workflows. AI tools can also highlight regions of interest, helping pathologists focus on the most critical areas and reducing diagnostic fatigue.

For a detailed review of current AI technologies in cancer diagnostics and treatment—including digital pathology—see this open-access article on AI technologies in cancer diagnostics and treatment .

AI-driven biomarker and molecular profiling

AI is also accelerating the discovery of prognostic and predictive biomarkers. By correlating image features, genomic alterations, transcriptomic signatures, and clinical outcomes, machine learning models can uncover patterns that indicate how a tumor will behave or respond to specific therapies.

Examples include:

• Radiomics: Extracting quantitative features from imaging scans to predict tumor aggressiveness, treatment response, or survival.
• Pathomics: Mining digital pathology images for micro-architectural patterns linked to prognosis or drug sensitivity.
• Multi-omics integration: Combining genomics, proteomics, metabolomics, and clinical data to build comprehensive predictive models.

These AI-driven approaches are helping researchers identify new therapeutic targets and refine existing classification systems, moving oncology closer to truly personalized medicine.

AI-guided treatment planning and precision therapy

Radiotherapy planning and optimization

Radiotherapy is a cornerstone of cancer treatment, but planning is complex: clinicians must deliver a lethal dose to the tumor while sparing healthy tissue. AI tools are now being used to automate and optimize key steps in this process, including contouring organs-at-risk, generating treatment plans, and predicting toxicity.

Deep learning models can rapidly segment tumors and critical structures on CT and MRI scans, reducing the time required for manual contouring. Optimization algorithms then generate treatment plans that balance tumor control with side-effect risk. Some systems can even learn from past plans and outcomes to continuously improve performance.

Reviews of AI-enabled tumor diagnosis and treatment highlight radiotherapy planning as one of the most mature clinical applications of AI in oncology.

AI in systemic therapy and combination regimens

AI is also being used to guide systemic therapies such as chemotherapy, targeted agents, and immunotherapies. Predictive models can estimate how likely a patient is to benefit from a particular regimen, or to experience severe toxicity. This information can help oncologists tailor treatment intensity, select alternative drugs, or enroll patients in clinical trials.

In immuno-oncology, AI is being applied to identify which patients are most likely to respond to checkpoint inhibitors or CAR-T cell therapies, based on tumor mutational burden, immune microenvironment features, and other biomarkers. As more real-world data becomes available, these models are expected to become increasingly accurate and clinically useful.

AI in robotic and image-guided cancer surgery

Robotic surgery has already transformed many cancer procedures by enabling minimally invasive approaches with enhanced precision. AI is now being layered on top of robotic platforms to provide real-time guidance, automate certain tasks, and improve safety.

AI can help surgeons:

• Identify anatomical structures: Highlight nerves, vessels, and tumor margins during surgery using augmented reality overlays.
• Plan resections: Use preoperative imaging and intraoperative data to optimize the extent of tumor removal.
• Monitor performance: Analyze instrument trajectories and force patterns to reduce complications and improve training.

As noted in recent reviews, AI-powered robotic surgery is associated with more precise procedures, shorter hospital stays, and lower infection risks when implemented appropriately.

AI in cancer drug discovery and clinical trials

Accelerating oncology drug discovery

Traditional drug discovery is slow and expensive, often taking more than a decade from target identification to regulatory approval. AI is helping compress this timeline by:

• Identifying novel targets: Mining genomic and proteomic data to find new molecular vulnerabilities in cancer cells.
• Designing candidate molecules: Using generative models to propose small molecules or biologics with desired properties.
• Predicting drug behavior: Estimating absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles before laboratory testing.
• Repurposing existing drugs: Discovering new cancer indications for approved medications based on real-world data and molecular signatures.

Several AI-designed oncology drugs have already entered clinical trials, demonstrating the potential of these methods to bring new therapies to patients faster.

For a broad perspective on AI in cancer research and future directions, see this review on artificial intelligence in cancer: applications, challenges, and future perspectives .

Optimizing clinical trials with AI

Clinical trials are essential for proving the safety and efficacy of new cancer treatments, but they are often hampered by slow recruitment, high costs, and complex eligibility criteria. AI can help by:

• Matching patients to trials: Automatically screening electronic health records and genomic data to identify eligible participants.
• Designing adaptive trials: Using Bayesian and machine learning methods to adjust trial parameters in real time based on emerging data.
• Monitoring safety: Detecting early signals of adverse events or lack of efficacy to protect participants and refine protocols.

These innovations can make trials more efficient, inclusive, and informative—ultimately speeding the delivery of new cancer therapies to the clinic.

Real-world data, survivorship, and AI-powered support

Learning from real-world evidence

Beyond controlled trials, AI is increasingly used to analyze real-world data from registries, claims databases, wearable devices, and patient-reported outcomes. This information can reveal how treatments perform outside of academic centers, identify disparities in care, and uncover long-term effects that may not be apparent in shorter studies.

AI models can also help health systems monitor quality metrics, predict resource needs, and design interventions to improve equity and access to cancer care.

Supporting patients and caregivers

AI-driven tools are being developed to support patients and caregivers throughout the cancer journey. Examples include:

• Symptom monitoring apps: Mobile tools that track side effects and alert clinicians when intervention is needed.
• Virtual navigators: Chatbots and digital assistants that help patients understand their diagnosis, appointments, and treatment options.
• Mental health and survivorship support: AI-enabled platforms that provide tailored educational content and connect patients to resources.

While these tools are not a substitute for human care, they can complement clinical teams and help patients feel more informed and supported.

Ethical, regulatory, and practical challenges

Bias, transparency, and trust

Despite its promise, AI in oncology faces significant challenges. Models trained on biased or incomplete data may perform poorly for underrepresented populations, potentially exacerbating health disparities. Lack of transparency in how models make decisions can undermine clinician trust and make it difficult to explain recommendations to patients.

Addressing these issues requires:

• Diverse, high-quality datasets: Ensuring that training data reflects the full spectrum of patients and care settings.
• Explainable AI: Developing methods that provide interpretable insights rather than opaque predictions.
• Robust validation: Testing models prospectively and across multiple institutions before clinical deployment.

Regulation and clinical integration

Regulators such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are developing frameworks for evaluating AI-based medical devices and software. Clinicians and health systems must integrate AI tools into workflows in ways that enhance, rather than hinder, care.

Successful integration depends on:

• Clear clinical use cases: Defining where AI adds value and how it will be used in practice.
• Training and education: Helping clinicians understand AI capabilities, limitations, and best practices.
• Continuous monitoring: Tracking performance over time and updating models as new data emerges.

Looking ahead: The future of AI in the fight against cancer

The trajectory of AI in oncology is unmistakable: from experimental tools to essential infrastructure. As multimodal data integration, generative models, and federated learning mature, AI systems will become more powerful, more collaborative, and more embedded in everyday cancer care.

Key trends to watch include:

• Multimodal precision oncology platforms: Unified systems that integrate imaging, pathology, genomics, and clinical data to guide decisions in real time.
• AI-assisted prevention strategies: Population-level models that identify modifiable risk factors and inform public health interventions.
• Global collaboration: Cross-institutional data sharing and federated learning that allow models to learn from diverse populations without compromising privacy.

As highlighted in recent high-impact reviews, AI’s contributions to precision oncology are becoming one of the defining hallmarks of modern cancer care. When implemented responsibly, AI will not replace oncologists, radiologists, or pathologists—but it will profoundly augment their ability to prevent, detect, and treat cancer more effectively.

For clinicians, researchers, and patients alike, the message is clear: AI is no longer a distant promise. It is an active, evolving partner in the global fight against cancer, offering new tools, new insights, and new hope across all forms of the disease.

Huntington’s Disease: Causes, Genetics, Symptoms, Treatment Options, and Breakthrough Research

Huntington’s Disease (HD) is a rare, inherited neurodegenerative disorder caused by a mutation in the HTT gene that leads to toxic CAG repeat expansion. Symptoms typically appear between ages 30 and 50 and include involuntary movements, cognitive decline, and emotional changes. Juvenile HD is a more aggressive early‑onset variant. Each child of an affected parent has a 50% chance of inheriting the mutation. Although HD cannot be cured, symptoms can be managed through medications, supportive therapies, and multidisciplinary care. Current treatments focus on chorea reduction, mood stabilization, and improving daily functioning. Cutting‑edge research is advancing rapidly, including gene‑silencing therapies, somatic expansion inhibitors, and gene‑editing approaches. Recent discoveries highlight roles for neuroinflammation, RNA clustering, and cortical disinhibition in HD progression. This comprehensive guide explores causes, symptoms, genetics, prevalence, management strategies, and the latest breakthroughs shaping the future of Huntington’s Disease treatment.

Huntington’s Disease: A Comprehensive, Authoritative Guide

Huntington’s Disease (HD) is a progressive, inherited neurodegenerative disorder caused by a mutation in the HTT gene. This mutation leads to an abnormal expansion of CAG nucleotide repeats, resulting in the production of a toxic form of the huntingtin protein. Over time, this protein damages neurons in critical brain regions responsible for movement, cognition, and emotional regulation.

What Is Huntington’s Disease?

HD causes gradual deterioration of nerve cells, particularly in the basal ganglia and cerebral cortex. Symptoms typically appear between ages 30 and 50, though early‑onset cases occur in children and adolescents.

Common Symptoms

• Chorea (involuntary, jerking movements)
• Cognitive decline, including difficulty planning and focusing
• Mood disorders such as depression, irritability, and apathy
• Speech, swallowing, and gait difficulties

Who Is Affected?

HD affects males and females equally and occurs across all ethnic groups. It is considered rare, but its impact on individuals and families is profound.

Genetics: What Are the Chances a Child Will Inherit HD?

Huntington’s Disease follows an autosomal dominant inheritance pattern. This means:

• If a parent has HD, each child has a 50% chance of inheriting the mutated gene.
• If the child does not inherit the mutation, they will not develop HD and cannot pass it on.

Genetic testing can confirm whether an individual carries the mutation, though testing is typically accompanied by genetic counseling due to the emotional and ethical considerations involved.

Variants of Huntington’s Disease

Adult-Onset HD

The most common form, typically beginning in mid-adulthood. Symptoms progress gradually over 10-25 years.

Juvenile Huntington’s Disease (JHD)

A rare variant appearing before age 20. JHD progresses more rapidly and may include rigidity, seizures, and academic decline.

Prevalence: How Many People Have HD?

Huntington’s Disease is rare. In the United States, approximately 30,000 people are living with HD, and another 200,000 are at risk due to family history. Worldwide prevalence is similarly low, though HD occurs in all populations.

Can Huntington’s Disease Be Cured?

There is currently no cure for Huntington’s Disease. Existing treatments cannot stop or reverse neuronal degeneration. However, significant progress in genetic and molecular research is bringing scientists closer to disease‑modifying therapies.

Can Huntington’s Disease Be Managed?

Yes. While HD cannot be cured, symptoms can be effectively managed through medications, supportive therapies, and multidisciplinary care.

Medications

• VMAT2 inhibitors (tetrabenazine, deutetrabenazine) to reduce chorea
• Antipsychotics for mood stabilization and behavioral regulation
• Antidepressants for depression and anxiety

Supportive Therapies

• Physical therapy to maintain mobility
• Occupational therapy to support daily functioning
• Speech therapy for communication and swallowing
• Nutritional support to prevent weight loss

Latest Discoveries and Emerging Treatments

Gene-Silencing Therapies

Researchers are developing antisense oligonucleotides (ASOs) and RNA-targeted therapies that reduce production of the mutant huntingtin protein.

Somatic Expansion Inhibition

New studies show that preventing further CAG repeat expansion in neurons may slow disease progression.

Gene Therapy

Experimental gene-editing approaches aim to modify or replace the faulty HTT gene. These therapies require precise timing and delivery.

Neuroprotective Strategies

Research highlights roles for mitochondrial support, anti-inflammatory pathways, and excitotoxicity reduction.

Recent Breakthroughs

• Discovery of astrocytic lipid dysregulation as a driver of neurodegeneration
• Structural insights into MLH1–FAN1 interactions regulating CAG repeat expansion
• Restoring cortical disinhibition improves motor deficits in HD models
• Identification of dynamic nuclear RNA clusters formed by mutant HTT mRNA
• Neuroinflammatory transcriptomic changes linked to motor symptoms

Authoritative Resources

• National Institute of Neurological Disorders and Stroke
• Huntington’s Disease Society of America
• Mayo Clinic: Huntington’s Disease

Contraceptives and the Catholic Church

Question: Are contraceptives ever allowed by the Catholic Church?

Answer: Yes, contraceptives can be morally licit and therefore allowed by the Catholic Church in certain circumstances.

Contraceptives, commonly known as birth control, are routinely prescribed for hormonal regulation and to treat or manage a variety of other health conditions. Preventing pregnancy, in these cases, is not the primary motive, and is merely a foreseen consequence of taking them. Furthermore, according to the Moral Rape Protocol, Catholic hospitals may administer contraceptives after a rape, provided that their use does not lead to the destruction of an egg that has already been fertilized, or prevent a fertilized egg from implanting. This would constitute a direct abortion, which is always a grave evil and therefore always prohibited. It should be noted here at the time of this writing in 2026 that the Moral Rape Protocol is currently a debated subject, with some Catholic ethicists finding it permissible and others seeing it as morally problematic. In any case, it's when using contraceptives with the primary aim of blocking pregnancy (other than the Moral Rape Protocol just discussed) that such use is always a grave evil and therefore always prohibited, just as with a direct abortion.

For additional information, refer to the previous post, The Catholic Church’s Teaching on Artificial Contraception and Moral Alternatives.

The Catholic Church’s Teaching on Artificial Contraception and Moral Alternatives

Note: This article was originally written for a biomedical ethics class taken by the author during the summer of 2026 in his pursuit of a Master of Arts in Theology degree. The article is brief and written in a pastoral style fit for use in a weekly parish bulletin, per the requirements of the assignment.

The Catholic Church teaches that artificial contraception is morally unacceptable when used to deliberately prevent pregnancy. This article explains the Church’s reasoning, showing how contraception separates the marital act from its God‑given purpose and diminishes authentic self‑giving love. It also explores situations where physicians may prescribe contraceptives for legitimate medical reasons, clarifying how intent matters morally. Readers will learn about Natural Family Planning (NFP) as a healthy, effective, and Church‑approved alternative for responsibly spacing children or supporting fertility. The article also highlights abstinence as the appropriate choice for those not married. Written in a pastoral, supportive tone, this resource helps individuals and couples understand Church teaching, navigate questions or pressures they may face, and discern moral options with confidence. A brief bibliography offers trusted sources for deeper study, including Humanae Vitae and the U.S. bishops’ Ethical and Religious Directives.

Aaron S. Robertson

July 5, 2026

The Catholic Church’s Teachings on the Uses of Artificial Contraception and Their Moral Alternatives

You may be wondering, “What is the Catholic Church’s official teaching on artificial contraception?” Perhaps you’ve heard bits and pieces but have never explored the subject with any real rigor or research. Maybe you’re thinking of using artificial forms of contraception yourself, which can come in many forms and are collectively known simply as “birth control,” and you have questions, concerns, and doubts. It could be that your physician or partner - even your spouse - is pressuring you into considering this avenue. Perhaps many of your friends are using some form of birth control, so it all seems “normal.” Whatever your situation, concerns, or curiosities about artificial contraception, we look to explain here, in a loving and pastoral way, the Church’s teaching on the matter. In doing so, we will also explain the why behind Holy Mother Church’s positions on this subject. We will close by offering healthy and moral alternatives to the uses of artificial contraception. At the very end of this article, please find a brief list of resources to help guide your discernment further. While this list is far from being comprehensive, it will serve as a solid starting point, with these resources pointing you to other references in turn.

To begin, and simply put, the Catholic Church holds that the use of artificial contraception - birth control - in all its forms, is always immoral, that is to say, gravely evil, when the primary goal of using it is to intentionally prevent pregnancy. Now, a physician may at times prescribe contraceptives for something other than the main aim of blocking the formation of human life if other treatment options are not available. Birth control has been used for decades to treat or manage an array of legitimate health conditions, like hormonal regulation. Preventing pregnancy, in these cases, is a foreseen but unintentional consequence. In other words, we know that by taking the contraceptive, pregnancy is bound to be blocked by the mere fact that it’s birth control, but this wasn’t our main objective in taking it. This would be a conversation to have with your doctor and perhaps in consultation with your pastor.

Why is this? Why does Holy Mother Church take this stance, that the use of birth control in any form is always gravely evil when the primary goal of the user is to purposely inhibit pregnancy? It’s because it abuses and corrupts the intended purpose of the gift of our human sexuality as God designed it to be. Sexual intercourse, then, has always been meant to be the complete giving of one’s self to another, enjoyed between one man and one woman joined together exclusively by almighty God in the sacrament of Holy Matrimony - marriage - for the sole purpose of being open to the possibility of generating a new life. When we seek to distort and block God’s intended purpose for our sexuality through the use of birth control, we use our partner(s), seeing them as nothing more than objects for our selfish desires. This is not, nor can it ever be, true love.

What are morally acceptable alternatives to artificial contraception? Natural Family Planning, or NFP for short, makes use of a woman’s natural, God-given cycle of fertility over the course of the month to either increase the chances of conceiving, or, during times when a married couple may have legitimate reason, to greatly decrease the chances of conceiving. These may include the reasonable spacing out of children, and/or concerns over the health of mother, among others. Making use of God’s design via this natural cycle, a married couple is free to enjoy the marital act during times of infertility, while abstaining from it during times of fertility, all without moral consequence. Finally, abstinence - that is, the refraining from all sexual activity - is morally acceptable, indeed mandated according to God’s Law and the teachings of His Church, for all who are not joined as one man and one woman in Holy Matrimony.

We hope you have found this information helpful. Whatever your situation, questions, or concerns may be, please know that you are never alone and that we as a pastoral staff and parish community are always here for you. Lean on the sacraments and on the combined counsel and wisdom of our community as you continue to discern these deeply important matters. God bless.

Bibliography

Paul VI. Humanae Vitae. Encyclical Letter. Vatican Website. July 25, 1968. https://www.vatican.va/content/paul-vi/en/encyclicals/documents/hf_p-vi_enc_25071968_humanae-vitae.html.

United States Conference of Catholic Bishops. Ethical and Religious Directives for Catholic Health Care Services. 7th ed. Washington, DC: USCCB, November 2025. https://www.usccb.org/resources/ERDs-7th-ed-Approved_2025-11-12.pdf.

Is Law School Worth It? Costs, Careers, Admissions & Scholarships Guide

This comprehensive guide helps students evaluate whether law school is worth the investment by breaking down admissions requirements, LSAT preparation, tuition costs, career paths, and scholarship opportunities. Readers learn what law schools look for, how much a J.D. typically costs, and how salaries vary across legal specialties. The article highlights practical alternatives within the legal field, including government roles, nonprofit work, and compliance careers. It also features details on the HKM Employment Attorneys Scholarship, including eligibility, award amounts, participating cities, and deadlines. Additional FAQs cover choosing a major, the timeline to become a lawyer, the value of lower‑ranked schools, and tips for writing strong scholarship essays. This resource is ideal for pre‑law students, paralegals, and anyone exploring a legal career, offering actionable guidance to make informed decisions about law school, financial planning, and community‑focused legal education.

Is Law School Worth It? What Students Should Know Before Choosing a Legal Career

Thinking about law as a career is one thing. Actually understanding what the path looks like is another. Before committing to years of school and significant debt, here is a straightforward look at what law school involves, what you can do with a degree, and how to make it more affordable.

Getting in

Law school is a graduate program, so a bachelor's degree comes first. You do not need a specific major -- what schools are really looking for is strong writing and the ability to reason through an argument. Your undergraduate GPA and your score on the Law School Admission Test (LSAT) carry the most weight, along with your personal statement and letters of recommendation. Students who want structured prep resources ahead of the exam will find a range of options through providers like Kaplan Test Prep and Princeton Review.

What does it cost?

Private law school tuition can run well over $50,000 a year, and three years can easily top $200,000 in total costs. Public schools are more affordable, especially for in-state students. Law does remain one of the higher-earning professions -- the U.S. Bureau of Labor Statistics puts lawyer salaries well above the national median -- but starting pay varies a lot depending on the type of law you practice. A corporate associate at a big firm will earn far more than an attorney doing public interest work. Model your expected debt against your actual career goals, and use tools like Credible's student loan calculator to get a realistic picture before you commit.

What can you do with a law degree?

More than most people expect. Some common directions:

• Private practice at a firm, from large corporate outfits to small local offices
• Government roles including prosecutors, public defenders, and agency attorneys
• In-house counsel at companies, often with more predictable hours
• Nonprofit and public interest law for those drawn to advocacy and community impact
• Careers outside law entirely, including compliance, consulting, politics, and finance

Scholarships that can help with the cost

One of the smartest moves you can make is to look for scholarships early and often. Funding exists through schools, bar associations, and legal organizations that invest in the next generation of attorneys. Checking directly with your state's bar association is a good place to start, since many run their own local programs. Law school prep tools like Magoosh LSAT are also worth budgeting for early so you are not scrambling later.

One active example worth knowing about is the annual scholarship program from HKM Employment Attorneys, a national firm that exclusively represents employees in workplace discrimination, wrongful termination, harassment, and wage cases. In 2025, HKM distributed $24,000 across 24 students in 23 cities. The 2026 program has expanded to 37 cities, with $1,000 awards open to students in pre-law, paralegal, or J.D. programs at campuses within 60 miles of a participating location.

To be eligible, applicants need a 3.0 GPA or higher and a short essay responding to the prompt: "How I will use my legal education to serve my community." The deadline is October 15, 2026. Students near Chicago, Minneapolis, Indianapolis, or Kansas City are among those who can apply. The full city list is in the FAQ below.

Frequently asked questions

What major should I choose for law school?

There is no required major. Political science, history, philosophy, psychology, and English are popular, but students from almost any background get in. Focus on developing strong writing and reasoning skills. If you want help planning your path, a college advisor or a resource like College Board's major exploration tool can be a useful starting point.

How long does it take to become a lawyer?

Four years of undergrad plus three years of law school, then a bar exam. Most people are looking at eight or more years from the start of college to a license to practice. Bar prep courses through providers like Barbri or Themis Bar Review are a common final step before sitting for the exam.

Is a lower-ranked law school worth it?

Often, yes -- especially if you plan to practice locally and a strong scholarship makes it more affordable. School ranking matters more if you are targeting large national firms or competitive federal clerkships.

Where can I apply for the HKM Employment Attorneys Scholarship?

Students enrolled at a campus within 60 miles of any city listed below are encouraged to check their local scholarship page and apply before the October 15, 2026 deadline:

• Birmingham, Alabama -- hkm.com/birmingham
• Huntsville, Alabama -- hkm.com/huntsville
• Phoenix, Arizona -- hkm.com/phoenix
• Los Angeles, California -- hkm.com/los-angeles
• Oakland, California -- hkm.com/oakland
• Orange County, California -- hkm.com/irvine
• Riverside, California -- hkm.com/riverside
• Sacramento, California -- hkm.com/sacramento
• San Diego, California -- hkm.com/sandiego
• San Francisco, California -- hkm.com/san-francisco
• San Jose, California -- hkm.com/san-jose
• Denver, Colorado -- hkm.com/denver
• Atlanta, Georgia -- hkm.com/atlanta
• Boise, Idaho -- hkm.com/boise
• Chicago, Illinois -- hkm.com/chicago
• Indianapolis, Indiana -- hkm.com/indianapolis
• Baltimore, Maryland -- hkm.com/baltimore
• Boston, Massachusetts -- hkm.com/boston
• Minneapolis, Minnesota -- hkm.com/minneapolis
• Kansas City, Missouri -- hkm.com/kansascity
• St. Louis, Missouri -- hkm.com/stlouis
• Bozeman, Montana -- hkm.com/bozeman
• Las Vegas, Nevada -- hkm.com/lasvegas
• New Paltz, New York -- hkm.com/new-paltz
• New York City, New York -- hkm.com/new-york
• Charlotte, North Carolina -- hkm.com/charlotte
• Cincinnati, Ohio -- hkm.com/cincinnati
• Portland, Oregon -- hkm.com/portland
• Philadelphia, Pennsylvania -- hkm.com/philadelphia
• Pittsburgh, Pennsylvania -- hkm.com/pittsburgh
• Houston, Texas -- hkm.com/houston
• Arlington, Virginia -- hkm.com/arlington
• Bellevue, Washington -- hkm.com/bellevue
• Seattle, Washington -- hkm.com/seattle
• Spokane, Washington -- hkm.com/spokane
• Milwaukee, Wisconsin -- hkm.com/milwaukee
• Washington, D.C. -- hkm.com/washingtondc

What makes a strong scholarship essay?

Specificity. Name a real community, identify a real problem, and explain a concrete plan. Connect your background to a specific unmet legal need and describe how your education will help address it. Clear and honest beats impressive-sounding every time.

Should I retake the LSAT if I am not happy with my score?

In most cases, yes -- if you have a realistic reason to think you can do better. Law schools can see all of your scores, but most focus on the highest one. If your score is below the median for schools you are targeting, retaking is usually worth it. Give yourself enough prep time to make a meaningful improvement rather than retaking too quickly. Resources like 7Sage's analytics tools offer detailed analytics that can help you pinpoint exactly where you are losing points before you decide whether another attempt makes sense.

Building Kids’ Friendship Skills for Stronger Confidence at School

Building Strong Friendship Skills at Home for School Confidence

For parents of school-age children, few things feel as tender as watching a child struggle to connect at school. Social challenges in childhood can show up as loneliness at lunch, friendship “drama,” or getting stuck on the edges of group play, even when a child truly wants friends. Peer relationships at school move fast, and without steady friendship skills development, everyday moments can feel stressful and confusing. The importance of early socialization at home is that it gives kids a familiar foundation for empathy, conversation, and cooperation that makes friendships feel more natural.

What “Friendship Skills” Really Are

Friendship skills are the everyday behaviors kids use to start, grow, and repair relationships, not a popularity contest. A helpful friendship skills definition includes communication and empathy, which sit underneath conversation, sharing, and including others. As kids build empathy and perspective-taking, they get better at noticing feelings, reading the room, and responding kindly.

This matters because school friendships run on small moments: joining a game, handling “no,” and trying again after a mix-up. When kids can talk, cooperate, and include others, they feel more confident and classmates feel safer around them. That combination reduces daily stress and makes group work and recess smoother.

Think of friendship skills like a three-part toolkit: words, teamwork, and welcoming. “Words” is greeting, asking questions, and listening; “teamwork” is taking turns and sharing; “welcoming” is making space for someone new. Under it all is empathy, or understanding and sharing feelings, which helps kids choose what to say and do. Kid-friendly role-play scenes make these tools easier to practice without pressure.

Turn Friendship Practice Into Anime-Style Story Scenes

Once you can name the building blocks of friendship, it gets a lot easier to practice them in a way that feels light and memorable. One playful option is using an AI anime generator to turn kindness, teamwork, and inclusion into little story scenes you create together. Your child can start with simple text prompts (like a character inviting someone to join a game), then explore anime effects and style controls to shape the mood, expressions, and setting. Designing characters and moments this way can make “friendship skills” feel concrete: you’re not lecturing, you’re building a scene that shows what caring, welcoming behavior looks like.

As you make shared comics, quick storyboards, or single anime-style images, the process itself becomes practice: taking turns suggesting ideas, listening to each other’s input, negotiating small decisions, and cooperating toward a finished story. That low-pressure teamwork can boost confidence for real-life social situations at school, because your child has already rehearsed friendly conversation and shared decision-making at home.

Small Friendship Habits That Add Up

Friendship skills grow through lots of tiny reps, not one big talk. These habits give your child steady practice with language, timing, and confidence so school interactions feel more familiar each week.

Two-Minute Friend Prep

What it is: Practice one greeting, one question, and one kind comment before school.

How often: Daily.

Why it helps: It makes friendly words easier to access under pressure.

Feelings Check and Name

What it is: Ask “What might they feel?” while reading or watching short clips.

How often: 3 times a week.

Why it helps: Empathy improves collaboration and reduces misunderstandings.

Inclusion Cue Practice

What it is: Rehearse one inclusive line like “Want to join us?” during play.

How often: Weekly.

Why it helps: It builds leadership and belonging for everyone.

Turn-Taking Micro-Coaching

What it is: Narrate turns during games using “my turn, your turn, our turn.”

How often: During shared activities.

Why it helps: It lowers conflict and boosts cooperation.

Compliment and Gratitude Loop

What it is: At dinner, each person shares one appreciation from the day.

How often: 4 to 5 nights a week.

Why it helps: Strong social skills support mental health and school success.

Friendship Skills Q&A Parents Ask Most

Q: What if my child gets really anxious about talking to peers?

A: Start small and predictable: practice one simple opener at home, then set a “just try once” goal at school. Praise the effort, not the outcome, so they learn they can handle the feelings. If anxiety causes stomachaches, tears, or refusal to attend school for weeks, consider asking your pediatrician or school counselor for support.

Q: How can I help when my child says they’re always left out?

A: Validate first, then problem-solve: “That hurts. Let’s plan one next step.” Coach them to join a structured activity like clubs or small-group games where roles are clearer, and help them invite one classmate for a short, low-pressure playdate.

Q: Why does my child keep getting into conflicts over “fairness”?

A: Many kids need repeated practice with flexibility and repair after mistakes. Teach one calm script: “I didn’t like that. Can we try again?” Building social competence takes time, and conflict can be part of learning.

Q: When should I step in versus letting kids work it out?

A: Step in for unsafe behavior, repeated targeting, or power imbalances. Otherwise, coach afterward by naming what happened, what they wanted, and one different choice for next time.

Q: Can a shy child still build strong friendships?

A: Yes. One steady friend can be enough for a great school experience, and social and emotional development supports success beyond the playground. Help them find “quiet-friendly” settings like reading corners, art, or building activities.

Keep Friendship Skills Growing With One Small Weekly Goal

Kids can want friends and still freeze up, misread signals, or get pulled into the same conflicts again and again. The steadier path is a supportive, low-pressure mindset: ongoing parental involvement that keeps modeling empathy, practicing calm communication, and reinforcing friendship lessons in everyday moments. Over time, that consistency builds confidence, nudges kids toward healthier choices, and keeps motivating children’s social success at school. Small, steady social practice beats big, one-time talks.

Permissions & Sharing Policy for Educational Use | Mr. Robertson’s Corner

Permissions & Sharing Policy

Encouraging Learning, Conversation, and the Free Exchange of Ideas

Learning grows when ideas are shared. One of the core purposes of Mr. Robertson’s Corner is to support students, families, educators, catechists, and lifelong learners by making thoughtful, well‑crafted educational content freely accessible.

To that end, we warmly encourage you to share, cite, print, adapt, and use the materials on this blog for non‑commercial educational purposes, as long as proper attribution is included.

---

Why We Encourage Sharing

Education thrives when resources circulate. Whether you are preparing a lesson, leading a study group, tutoring a student, writing a research paper, putting together a presentation, or simply exploring a topic on your own, you are welcome to use the content here to:

• Support classroom instruction
• Enrich parish or ministry programs
• Create handouts, worksheets, slides, or study guides
• Spark discussion in small groups
• Assist with research or academic work

Our goal is simple: Spread knowledge. Foster curiosity. Encourage deeper thinking.

---

The License That Makes This Possible

All original content on this blog is licensed under the Creative Commons Attribution–NonCommercial 4.0 International License (CC BY‑NC 4.0).

This means you are free to:

• Share — copy and redistribute the material
• Adapt — remix, transform, and build upon it
• Use — incorporate it into lessons, presentations, papers, handouts, or study materials

As long as:

1. You credit the respective author/s of the post (it could be Aaron S. Robertson, and/or a guest author, or no author listed)
2. You link back to the content's original page
3. You do not use the material commercially

You can read the full license here:
https://creativecommons.org/licenses/by-nc/4.0/

---

How to Cite This Blog’s Content

Here is an example of a simple, recommended citation format:

Content by Aaron S. Robertson [and/or other author/s], originally published at www.mrrobertsonscorner.com . Used under CC BY‑NC 4.0.

If no specific author listed on a post:

Originally published at www.mrrobertsonscorner.com . Used under CC BY‑NC 4.0.

You may certainly adjust the format to match your school, institution, or publication style.

---

Examples of Acceptable Educational Use

You are welcome to:

• Print articles or excerpts for classroom use
• Include excerpts in lesson plans
• Use diagrams or explanations in presentations
• Share posts with students or colleagues
• Incorporate material into study guides or review sheets

As long as you credit the source and keep it non‑commercial, you are welcome to use the content in these ways.

---

What Isn’t Allowed

To protect the integrity of the work, the following are not permitted without written permission:

• Commercial use (selling, monetizing, paywalled courses, etc.)
• Reposting entire articles without attribution
• Using the content in AI‑generated products without credit

If you ever need broader permissions, please reach out to discuss your specific use case.

---

A Final Word

Thank you for valuing learning, curiosity, and thoughtful engagement. By sharing responsibly, you help this blog reach more students, families, educators, and lifelong learners — and you help build a culture where knowledge is freely exchanged and deeply appreciated.

If you have questions about using or citing the content, we are always happy to help.